Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Covington
Medtronic
Boehringer Ingelheim
Citi
Farmers Insurance

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 9,421,205

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,421,205
Title:FAK inhibitors
Abstract: A compound of the formula (I): ##STR00001## where R.sup.1 or R.sup.2 is a cyclic amine group and R.sup.5 is an aromatic group with a carbonyl containing substituent for use as a FAK inhibitor.
Inventor(s): Holmes; Ian Peter (Bundoora, AU), Bergman; Yiva (Parkville, AU), Lunnis; Gillian Elizabeth (Parkville, AU), Nikac; Marica (Parkville, AU), Choi; Neil (Parkville, AU), Hemley; Catherine Fae (Parkville, AU), Walker; Scott Raymond (Parkville, AU), Foitzik; Richard Charles (Parkville, AU), Ganame; Danny (Bundoora, AU), Lessene; Romina (Bundoora, AU)
Assignee: Cancer Therapeutics CRC PTY LTD. (Bundoora, AU)
Application Number:14/619,674
Patent Claims:see list of patent claims

Details for Patent 9,421,205

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up Cancer Therapeutics CRC PTY LTD. (Bundoora, AU) 2031-02-17 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up Cancer Therapeutics CRC PTY LTD. (Bundoora, AU) 2031-02-17 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cipla
Fuji
McKinsey
US Army
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.